Loading viewer...
earnings
Format: PDF earnings
Sika's investor presentation covering nine-month 2023 results, highlighting 12.4% sales growth driven by the MBCC acquisition and significant profitability improvements in Q3. The presentation also outlines the company's new strategy for 2028 and future outlook.
presentation
earnings
36 Pages
SM Energy
Teva Pharmaceutical Q4 2023 Earnings Results
earningsearnings
56 Pages
Teva Pharmaceutical Industries Ltd.